Showing 1 - 16 results of 16 for search 'Guy A. Caldwell', query time: 0.04s
Refine Results
-
1
Back to the future through the wormhole: Caenorhabditis elegans as a preclinical model by Guy A. Caldwell
Published 2023-06-01
Article -
2
-
3
-
4
-
5
-
6
Xanthine Dehydrogenase Is a Modulator of Dopaminergic Neurodegeneration in Response to Bacterial Metabolite Exposure in <i>C. elegans</i> by Jennifer L. Thies, Karolina Willicott, Maici L. Craig, Madeline R. Greene, Cassandra N. DuGay, Guy A. Caldwell, Kim A. Caldwell
Published 2023-04-01
Article -
7
-
8
Attenuation of Dopaminergic Neurodegeneration in a <i>C. elegans</i> Parkinson’s Model through Regulation of Xanthine Dehydrogenase (XDH-1) Expression by the RNA Editase, ADR-2 by Lindsey A. Starr, Luke E. McKay, Kylie N. Peter, Lena M. Seyfarth, Laura A. Berkowitz, Kim A. Caldwell, Guy A. Caldwell
Published 2023-05-01
Article -
9
Chemical Compensation of Mitochondrial Phospholipid Depletion in Yeast and Animal Models of Parkinson's Disease. by Shaoxiao Wang, Siyuan Zhang, Chuan Xu, Addie Barron, Floyd Galiano, Dhaval Patel, Yong Joo Lee, Guy A Caldwell, Kim A Caldwell, Stephan N Witt
Published 2016-01-01
Article -
10
ApoE-associated modulation of neuroprotection from Aβ-mediated neurodegeneration in transgenic Caenorhabditis elegans by Edward F. Griffin, Samuel E. Scopel, Cayman A. Stephen, Adam C. Holzhauer, Madeline A. Vaji, Ryan A. Tuckey, Laura A. Berkowitz, Kim A. Caldwell, Guy A. Caldwell
Published 2019-02-01
Article -
11
Mechanistic impacts of bacterial diet on dopaminergic neurodegeneration in a Caenorhabditis elegans α-synuclein model of Parkinson’s disease by Anthony L. Gaeta, Karolina Willicott, Corey W. Willicott, Luke E. McKay, Candice M. Keogh, Tyler J. Altman, Logan C. Kimble, Abigail L. Yarbrough, Kim A. Caldwell, Guy A. Caldwell
Published 2023-06-01
Article -
12
Systemic RNA Interference Defective (SID) genes modulate dopaminergic neurodegeneration in C. elegans. by Anthony L Gaeta, J Brucker Nourse, Karolina Willicott, Luke E McKay, Candice M Keogh, Kylie Peter, Shannon N Russell, Shusei Hamamichi, Laura A Berkowitz, Kim A Caldwell, Guy A Caldwell
Published 2022-08-01
Article -
13
Investigating bacterial sources of toxicity as an environmental contributor to dopaminergic neurodegeneration. by Kim A Caldwell, Michelle L Tucci, Jafa Armagost, Tyler W Hodges, Jue Chen, Shermeen B Memon, Jeana E Blalock, Susan M DeLeon, Robert H Findlay, Qingmin Ruan, Philip J Webber, David G Standaert, Julie B Olson, Guy A Caldwell
Published 2009-10-01
Article -
14
Therapeutic genetic variation revealed in diverse Hsp104 homologs by Zachary M March, Katelyn Sweeney, Hanna Kim, Xiaohui Yan, Laura M Castellano, Meredith E Jackrel, JiaBei Lin, Edward Chuang, Edward Gomes, Corey W Willicott, Karolina Michalska, Robert P Jedrzejczak, Andrzej Joachimiak, Kim A Caldwell, Guy A Caldwell, Ophir Shalem, James Shorter
Published 2020-12-01
Article -
15
Lipase regulation of cellular fatty acid homeostasis as a Parkinson’s disease therapeutic strategy by Saranna Fanning, Haley Cirka, Jennifer L. Thies, Jooyoung Jeong, Sarah M. Niemi, Joon Yoon, Gary P. H. Ho, Julian A. Pacheco, Ulf Dettmer, Lei Liu, Clary B. Clish, Kevin J. Hodgetts, John N. Hutchinson, Christina R. Muratore, Guy A. Caldwell, Kim A. Caldwell, Dennis Selkoe
Published 2022-06-01
Article -
16
Neurodegenerative VPS41 variants inhibit HOPS function and mTORC1‐dependent TFEB/TFE3 regulation by Reini E N van der Welle, Rebekah Jobling, Christian Burns, Paolo Sanza, Jan A van der Beek, Alfonso Fasano, Lan Chen, Fried J Zwartkruis, Susan Zwakenberg, Edward F Griffin, Corlinda ten Brink, Tineke Veenendaal, Nalan Liv, Conny M A van Ravenswaaij‐Arts, Henny H Lemmink, Rolph Pfundt, Susan Blaser, Carolina Sepulveda, Andres M Lozano, Grace Yoon, Teresa Santiago‐Sim, Cedric S Asensio, Guy A Caldwell, Kim A Caldwell, David Chitayat, Judith Klumperman
Published 2021-05-01
Article